Wait...So Personality Actually Shapes Your Trip?

Plus, cacao vs. ayahuasca in the mainstream media and Darkside of the Spoon

Powered By

Good morning and welcome back to the Drop In, DoubleBlind’s newsletter serving up independent journalism about psychedelics straight to your inbox!

Ever wonder why some people have mystical, healing, or therapeutic psychedelic journeys, while others writhe under harrowing forces from the underworld? Today’s lead story offers a theory as to why this might be. If you keep scrolling you’ll find pieces on why legacy media should stop sending writers to parachute into psychedelic spaces and just hire reporters who cover the beat full time; a court rule in India that found mushrooms are not narcotics; and the ways in which psychedelics are entering university classrooms.

Plant seeds 🌿,

Mary Carreón
Editor-in-Chief

Together With Confluence Retreats

A Trusted Space for Psilocybin Journeys in Oregon

Confluence Retreats is a nonprofit organization that offers licensed, small-group psilocybin retreats in a serene Oregon setting. Our mission is to make safe, intentional journeys accessible and guided by care, not commercial pressures. Led by facilitators with years of experience in the field, we’re proud to be the most reviewed licensed psilocybin retreat center in the USA.

Our multi-day retreats combine thoughtful preparation, two psilocybin sessions, and extensive integration support in a safe, community-based environment.

For DoubleBlind readers only: the first 10 people to book a free exploration call will receive a $500 discount code; the next 15 will receive $250. First-come, while codes last.

Your first step is to book a free exploration call—a relaxed space to share your intentions, ask questions, and decide if this kind of immersive retreat feels right for you.

Your Personality May Shape the Course of a Psychedelic Trip, Study Says

New research suggests that traits like openness can make psychedelic experiences more mystical and transformative, while neuroticism may leave users vulnerable to unsettling effects.

Ever wonder why some people have mystical psychedelic journeys while others have harrowing experiences with visions of demons oozing from the bowels of the underworld? According to new research, our personalities may have something to do with that, PsyPost reports.

These findings add nuance to the current wave of psychedelic research, which often emphasizes average results while glossing over individual differences. Substances such as psilocybin, LSD, and DMT are known to induce experiences often called “ego deaths” and alter perception in ways that can be therapeutic. Yet, the same compounds are also notorious for unleashing terror, anxiety, or emotional chaos. So, what determines whether a trip ends in profound revelation or soul-wrenching despair?

Researchers framed their inquiry through the Big Five personality model — openness, conscientiousness, extraversion, agreeableness, and neuroticism — one of psychology’s most widely accepted frameworks. By aligning these traits with psychedelic experiences, the authors hoped to shed light on why different people react so differently to the same drugs. “Applying individual differences in personality traits to one of the most phenomenologically interesting experiences a human being arguably can have is, of course, in the interest of psychological research,” explained Petri J. Kajonius, an associate professor of personality psychology and assessment at Lund University in Sweden.

Because psychedelic use is prohibited in Sweden, the team relied on an anonymous online survey. 400 participants, with an average age of 34 and one-third of whom were women, were recruited through social media. Most had used psilocybin or LSD, often outdoors and sometimes with a “trip sitter” present. They were asked to recall their single most impactful psychedelic experience, typically from their early 20s, and to rate how challenging or mystical it was and how it had shaped their lives since. They also completed a 30-item Big Five personality assessment.

The experiences were overwhelmingly described as “meaningful.” 82 percent of respondents placed their psychedelic experience among the top 10 most significant events in their lives, 56 percent in the top five, and 11 percent as the most significant of all. On a scale of zero to five, the average trip was rated moderately challenging (3.14) and even more mystical (3.63). Long-term consequences tilted heavily positive: Negative aftereffects barely registered at 0.14, while positive life changes averaged a robust 4.26.

Openness proved the strongest predictor of positive outcomes. Participants high in openness were more likely to describe mystical qualities and lasting personal growth. “The Big Five trait Openness seems to be a very strong predictor for many outcomes before, during, and after a psychedelic experience,” Kajonius told PsyPost.

Neuroticism, by contrast, leaned in the opposite direction, with those high in this trait more prone to negative consequences and less likely to report benefits. The researchers calculated that higher neuroticism increased the likelihood of negative aftereffects by 56 percent. While modest, the effect underscores the vulnerability of people with anxious or volatile dispositions. Other traits carried less influence, though conscientiousness showed a small positive link with life improvements, while extraversion and agreeableness were only minor players.

“Our study again gives evidence that not only dose and context matter, but also the person, the psychological constitution of the individual taking the psychedelic substance,” Kajonius said. “For instance, neurotic persons should take extra caution, while open-minded persons tend to explore and grow in their personality in regard to psychedelics.”

Of course, the study has limitations. The sample was self-selected and, as Kajonius said, “very, very skewed towards psychonauts,” which likely means the pool leaned heavily toward people with especially profound or positive experiences. Psychedelics themselves may also alter personality traits, raising the question of whether openness and neuroticism shape the trip, or whether the trip shapes the personality. Some research suggests psychedelics can increase openness and decrease neuroticism over time.

Future studies could address these questions with larger and more diverse samples, assessments before and after psychedelic use, and controlled trials. For now, the message is clear: Who you are when you take psychedelics matters, perhaps as much as the setting or the dose.

Sneak Peek

We’ve Entered the Luxurious Bling-Era of Ketamine

This Friday, we’re dropping another WILD story about ketamine culture — and it all starts at a massive, beloved electronic music festival, where spoons have become a must-have accessory. From packed vendor stalls to whispered tales of a rogue spoon emporium, these tools aren’t just kitchen utensils anymore. They’re symbols of a culture pushing against the mainstream.

At the heart of spoon culture is a mysterious figure who’s turned a simple piece of drug paraphernalia into something closer to usable art. What does it mean when ketamine gets its own iconographic symbol — and what does that say about the rave generation carrying it?

Upgrade your subscription to get the full story in your inbox Friday morning.

& More Must-Reads

🌿 This opinion piece (second story down) is about that one time the L.A. Times wrote a story calling cacao “ayahuasca-lite,” highlighting how uninformed legacy media is when covering the psychedelic beat. Read more.

🍄 India’s courts just cracked open a legal gray area around psilocybin mushrooms — but does this ruling mark a real shift, or just another wrinkle in the country’s drug laws? Read more.

🎓 From counterculture to coursework, universities from California to Canada are rolling out the world’s first psychedelic degree programs — and redefining how we study consciousness, healing, and culture. Read more.

🍭 From ancient rituals to candy aisles, mushroom gummies are the latest twist in psychedelic consumption — here’s what they are, how they work, and what to watch out for. Read more.

🤖 What happens when artificial intelligence meets psychedelic medicine? A new paper suggests this unlikely pairing could transform everything from drug discovery to therapy itself. Read more.

DoubleBlind Digs

  • If you’ve ever attended an afterparty hosted by PORTAL, then you know how powerful (and fun!) destigmatizing psychedelics can be. Support PORTAL now during their $100K in 100 days fundraiser. Learn more here.

  • What’s the point of engaging in psychedelics culture without community? Support the Global Psychedelics Society and find helpful resources near you. Learn more here.

  • Johns Hopkins University is recruiting volunteers with chronic low back pain and depression for a study on psilocybin. The trial will explore whether psilocybin can ease both physical pain and mood symptoms in adults ages 21–80. Apply here.

  • Interested in cannabis and psilocybin research? Oregon State University’s SUN Lab is running an online survey on cannabis and psilocybin co-use, open to U.S. adults 18+. The 20–35 minute study is anonymous, and participants can enter a gift card raffle for completing it. Learn more and participate here.

*We may make a small commission from purchases using this link. Proceeds through advertising help to fund our independent journalism.

Together With Confluence Retreats

Oregon’s Highest-Rated Psilocybin Retreat


Confluence Retreats is a nonprofit offering licensed, small-group psilocybin retreats in a safe, community-based setting. We’re proud to be the highest-rated and most-reviewed licensed psilocybin retreat program in the U.S.

For DoubleBlind readers only: the first 10 to book a free exploration call get $500 off; the next 15 get $250. First-come, while codes last.

Around the Web

  • Cults are, uhhh, a thing in the psychedelic space. Here’s how to spot one. Read more from Psyche Magazine.

  • A new study suggests that just two psilocybin sessions can deepen faith and even make religious leaders more effective in their roles. Read more from PsyPost.

  • Here’s a story about what it feels like to keep dying on psychedelics. Read more here.

  • New research finds psilocybin not only alters minds but may also slow cellular aging and extend lifespan… at least in mice. Read more in Nature.

How was today's Drop In?

Login or Subscribe to participate in polls.

💌 If you loved this email, forward it to a psychonaut in your life.

Reply

or to participate.